With Biotene Acquisition, Glaxo Tries Again In Dry-Mouth Category
This article was originally published in The Rose Sheet
Executive Summary
GlaxoSmithKline expands its consumer oral-care business with the acquisition of Laclede's Biotene line of products indicated for dry mouth, or xerostomia